![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JG Umans and CE Inturrisi
Diacetylmorphine (DAM) and 6-acetylmorphine (AM) exhibit virtually identical dose-response and time-action profiles in studies in antinociceptive, excitatory, antidiarrheal and antidiuretic activity after subcutaneous administration to mice. In antinociceptive (Haffner tail clip, phenylquinone writhing and hot plate) and excitatory (Straub tail) tests, both drugs are 3 to 10 times more potent than morphine (M) and reach their peak effect more rapidly than M. Analysis of these data by graded and quantal methods establishes the comparability of the results obtained, while confirming the greater efficiency of the graded method. The durations of action of DAM and AM are shorter than that of M, yielding significant differences in potency estimates based upon peak vs. total effect. DAM and AM are only twice as potent as M in the suppression of prostaglandin E2-induced diarrhea and in antidiuretic activity. These pharmacodynamic studies, along with prior dispositional studies, suggest that the ability of DAM and AM to rapidly cross the blood-brain barrier determines their potency and time-action differences from M in centrally mediated bioassays. In contrast, DAM and AM are only slightly more potent than M in th antidiarrheal and antidiuretic test. These studies support the concept that the pharmacological effects of DAM are mediated principally by metabolically formed AM.
This article has been cited by other articles:
|
|
 |
|
  Y. A. Kolesnikov, M. Cristea, and G. W. Pasternak Analgesic Synergy Between Topical Morphine and Butamben in Mice Anesth. Analg., October 1, 2003; 97(4): 1103 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Platt, J. K. Rowlett, and R. D. Spealman Discriminative Stimulus Effects of Intravenous Heroin and Its Metabolites in Rhesus Monkeys: Opioid and Dopaminergic Mechanisms J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 760 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shimoyama, N. Shimoyama, G.-M. Zhao, P. W. Schiller, and H. H. Szeto Antinociceptive and Respiratory Effects of Intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1]DALDA J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 364 - 371. [Abstract] [Full Text]
|
|
|
|
|
|
Y. A. Kolesnikov, I. Chereshnev, and G. W. Pasternak Analgesic Synergy between Topical Lidocaine and Topical Opioids J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 546 - 551. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. J. Sim-Selley, D. E. Selley, L. J. Vogt, S. R. Childers, and T. J. Martin Chronic Heroin Self-Administration Desensitizes {micro} Opioid Receptor-Activated G-Proteins in Specific Regions of Rat Brain J. Neurosci., June 15, 2000; 20(12): 4555 - 4562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kest, S. G. Wilson, and J. S. Mogil Sex Differences in Supraspinal Morphine Analgesia Are Dependent on Genotype J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1370 - 1375. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Davis and C. E. Inturrisi d-Methadone Blocks Morphine Tolerance and N-Methyl-D-Aspartate-Induced Hyperalgesia J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1048 - 1053. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. A. Sporer Acute Heroin Overdose Ann Intern Med, April 6, 1999; 130(7): 584 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kolesnikov, S. Jain, R. Wilson, and G. W. Pasternak Lack of Morphine and Enkephalin Tolerance in 129/SvEv Mice: Evidence for a NMDA Receptor Defect J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 455 - 459. [Abstract] [Full Text]
|
|
|
|
|
|
B. Kest, G. McLemore, B. Kao, and C. E. Inturrisi The Competitive alpha -Amino-3-Hydroxy-5-Methylisoxazole-4-Propionate Receptor Antagonist LY293558 Attenuates and Reverses Analgesic Tolerance to Morphine But Not to Delta or Kappa Opioids J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1249 - 1255. [Abstract] [Full Text]
|
|
|
|
|
|
N. Shimoyama, M. Shimoyama, K. J. Elliott, and C. E. Inturrisi d-Methadone Is Antinociceptive in the Rat Formalin Test J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 648 - 652. [Abstract] [Full Text]
|
|
|
|
|
|
G. C. Rossi, L. Leventhal, E. Bolan, and G. W. Pasternak Pharmacological Characterization of Orphanin FQ/Nociceptin and its Fragments J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 858 - 865. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
